ATC code L02
From Self-sufficiency
| ATC codes |
|---|
| L Antineoplastic and immunomodulating agents |
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
ATC code L02 Endocrine therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L02 is part of the anatomical group L Antineoplastic and immunomodulating agents.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL02...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents
L02AA Estrogens
- L02AA01 Diethylstilbestrol
- L02AA02 Polyestradiol phosphate
- L02AA03 Ethinylestradiol
- L02AA04 Fosfestrol
L02AB Progestogens
- L02AB01 Megestrol
- L02AB02 Medroxyprogesterone
- L02AB03 Gestonorone
L02AE Gonadotropin-releasing hormone analogues
- L02AE01 Buserelin
- L02AE02 Leuprorelin
- L02AE03 Goserelin
- L02AE04 Triptorelin
L02AX Other hormones
L02BA Anti-estrogens
- L02BA01 Tamoxifen
- L02BA02 Toremifene
- L02BA03 Fulvestrant
L02BB Anti-androgens
- L02BB01 Flutamide
- L02BB02 Nilutamide
- L02BB03 Bicalutamide
L02BG Enzyme inhibitors
- L02BG01 Aminogluthetimide
- L02BG02 Formestane
- L02BG03 Anastrozole
- L02BG04 Letrozole
- L02BG05 Vorozole
- L02BG06 Exemestane
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />cs:ATC kód L02 es:Anexo:Código ATC L02 hu:ATC L02 – Endokrin terápia pl:ATC (L02) ro:Cod ATC L02 sv:ATC-kod L02: Endokrin terapi
th:ATC รหัส L02- ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology.
